Trusted by veterinarians around the world for over 35 years, IMRAB® vaccines help protect millions of animals each year from one of nature’s deadliest killers—rabies.1
IMRAB® Rabies Vaccines
Multi-Species Protection
When it comes to rabies prevention, there’s no room for compromise. IMRAB® 3 is the only vaccine that provides proven rabies protection for 6 animal species: dogs, cats, horses, cattle, sheep, and ferrets.2
Multi-Species Protection
When it comes to rabies prevention, there’s no room for compromise. IMRAB® 3 is the only vaccine that provides proven rabies protection for 6 animal species: dogs, cats, horses, cattle, sheep, and ferrets.2
1-Year & 3-Year Vaccines
Image
|
IMRAB® 1 and IMRAB® 1 TF
1-year rabies vaccine (dog, cat)
1-year rabies vaccine, thimerosal-free
(dog, cat)
Image
|
IMRAB® 3 and IMRAB® 3 TF
3-year rabies vaccine (dog, cat)*
3-year rabies vaccine, thimerosal-free
(dog, cat)**
*IMRAB® 3 is also approved as a 3-year rabies vaccine for sheep and a 1-year rabies vaccine for horses, cattle, and ferrets.
**IMRAB® 3 TF is also approved as a 1-year rabies vaccine for ferrets.
The History of IMRAB® Rabies Vaccines
Over 35 years ago in Georgia, local veterinarians were concerned about the spread of rabies from wild animals to their canine and feline patients.1 Boehringer Ingelheim Animal Health research team developed and created RABORAL V-RG®, an oral rabies vaccine for wildlife. Then, in collaboration with scientists from the University of Georgia, a strain from the original human rabies vaccine created by Louis Pasteur was used to create what would become the US market-leading rabies vaccine—IMRAB.3 The research and manufacturing facilities are still located in Athens, Georgia, and have been recently expanded to increase production capacity for the IMRAB, RECOMBITEK®, and PUREVAX® vaccine lines.
The History of IMRAB® Rabies Vaccines
Over 35 years ago in Georgia, local veterinarians were concerned about the spread of rabies from wild animals to their canine and feline patients.1 Boehringer Ingelheim Animal Health research team developed and created RABORAL V-RG®, an oral rabies vaccine for wildlife. Then, in collaboration with scientists from the University of Georgia, a strain from the original human rabies vaccine created by Louis Pasteur was used to create what would become the US market-leading rabies vaccine—IMRAB.3 The research and manufacturing facilities are still located in Athens, Georgia, and have been recently expanded to increase production capacity for the IMRAB, RECOMBITEK®, and PUREVAX® vaccine lines.
Rabies in the US
This map highlights the distribution of rabies virus variants (RVVs) among animals in the US, including Puerto Rico, from 2016 through 2020. For more information, click below to read the Journal of the American Veterinary Medical Association (JAVMA) published report: Rabies Surveillance in the United States During 2021.
Rabies in the US
This map highlights the distribution of rabies virus variants (RVVs) among animals in the US, including Puerto Rico, from 2016 through 2020. For more information, click below to read the Journal of the American Veterinary Medical Association (JAVMA) published report: Rabies Surveillance in the United States During 2021.
Satisfaction Guarantee
Our commitment starts with science and technology to help you protect your patients and continues with support for you and your clients. We will provide support in the event of a suspected adverse event (AE) or perceived lack of efficacy (LOE) associated with our vaccines and will provide reimbursement for any unused, expired doses, even if the vaccine tray has been opened.
RECOMBITEK® Canine Vaccines
RECOMBITEK® vaccines are highly purified, making them a safe and effective option to help protect your canine patients from dangerous diseases.
RECOMBITEK® Canine Vaccines
RECOMBITEK® vaccines are highly purified, making them a safe and effective option to help protect your canine patients from dangerous diseases.
IMRAB® Rabies Vaccines
Veterinarians worldwide trust US market-leading IMRAB® vaccines for proven multi-species rabies protection.4
IMRAB® Rabies Vaccines
Veterinarians worldwide trust US market-leading IMRAB® vaccines for proven multi-species rabies protection.4
PUREVAX® Feline Vaccines
Adjuvants can present potential risks to feline patients.5,6,7 PUREVAX® feline vaccines have been designed to elicit a protective immune response without the addition of adjuvants.
PUREVAX® Feline Vaccines
Adjuvants can present potential risks to feline patients.5,6,7 PUREVAX® feline vaccines have been designed to elicit a protective immune response without the addition of adjuvants.
RECOMBITEK® Canine Vaccines
RECOMBITEK® vaccines are highly purified, making them a safe and effective option to help protect your canine patients from dangerous diseases.
RECOMBITEK® Canine Vaccines
RECOMBITEK® vaccines are highly purified, making them a safe and effective option to help protect your canine patients from dangerous diseases.
IMRAB® Rabies Vaccines
Veterinarians worldwide trust US market-leading IMRAB® vaccines for proven multi-species rabies protection.4
IMRAB® Rabies Vaccines
Veterinarians worldwide trust US market-leading IMRAB® vaccines for proven multi-species rabies protection.4
PUREVAX® Feline Vaccines
Adjuvants can present potential risks to feline patients.5,6,7 PUREVAX® feline vaccines have been designed to elicit a protective immune response without the addition of adjuvants.
PUREVAX® Feline Vaccines
Adjuvants can present potential risks to feline patients.5,6,7 PUREVAX® feline vaccines have been designed to elicit a protective immune response without the addition of adjuvants.
References
- Data on file at Boehringer Ingelheim.
- IMRAB® 3 Product Label.
- Data on file at Boehringer Ingelheim.
- Data on file at Boehringer Ingelheim.
- Greene CE, Schultz RD. Immunoprophylaxis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St Louis, MO: Elsevier Saunders; 2012:1166-1169.
- McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. J Allergy Clin Immunol. 2018;141(2):463-472.
- Day MJ, Schoon H-A, Magnol J-P, et al. A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines. Vaccine. 2007; 25:4073-4084.
Trademarks
RECOMBITEK® and IMRAB® are registered trademarks and BI-CONNECT™ is a trademark of Boehringer Ingelheim Animal Health USA Inc. PUREVAX® is a registered trademark of Boehringer Ingelheim Animal Health France, used under license. ©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved.
US-PET-0234-2021-B-V2